# PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants

> **NCT05064800** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 24 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Dabigatran
- **DRUG:** PF-07321332/ritonavir + Dabigatran
- **DRUG:** Ritonavir + Dabigatran

## Key facts

- **NCT ID:** NCT05064800
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-21
- **Primary completion:** 2021-12-06
- **Final completion:** 2021-12-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05064800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05064800, "PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05064800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*